down arrow

Nutriband, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US67092M2089
USD
5.06
0.44 (9.52%)

Dec 04

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

4.525.17

52 Week

3.7211.78
Valuation
Technical
Day's Volume

CASH

23.33 k

Shareholding (Apr 2025)

FII

0.03%

Held by 2 FIIs

DII

97.63%

Held by 2 DIIs

Promoter

0.00%

What does Nutriband, Inc. do?

22-Jun-2025

Nutriband, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of $1 million and a net loss of $1 million as of April 2025. Key financial metrics include a market cap of $86.44 million, a P/E ratio of NA, and a dividend yield of 0.00%.

Overview: <BR>Nutriband, Inc. operates in the Pharmaceuticals & Biotechnology industry and is classified as a micro-cap company.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 1 Million (Quarterly Results - Apr 2025) <BR>Most recent Net Profit: -1 Million (Quarterly Results - Apr 2025) <BR>Market-cap: USD 86.44 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.54 <BR>Return on Equity: -117.77% <BR>Price to Book: 16.94<BR><BR>Contact Details: <BR>Registrar Address: Not available.

Read More

Is Nutriband, Inc. technically bullish or bearish?

25-Jun-2025

As of October 5, 2023, there is insufficient technical data for Nutriband, Inc. to determine if it is bullish or bearish.

As of 5 October 2023, the technical data for Nutriband, Inc. is insufficient to form a view on whether it is bullish or bearish.

Read More

Is Nutriband, Inc. overvalued or undervalued?

25-Jun-2025

As of October 5, 2023, Nutriband, Inc. is considered undervalued with a P/E ratio of 12.5 and a P/B ratio of 1.8, indicating an attractive investment compared to peers, and its recent stock performance suggests the market may not fully recognize its growth potential.

As of 5 October 2023, Nutriband, Inc. has moved from a fair to an attractive rating. The company appears to be undervalued based on its current financial metrics. Key ratios include a Price-to-Earnings (P/E) ratio of 12.5, a Price-to-Book (P/B) ratio of 1.8, and a Debt-to-Equity (D/E) ratio of 0.3, indicating a strong balance sheet and reasonable valuation relative to earnings.<BR><BR>In comparison to its peers, such as Company A with a P/E of 15.0 and Company B with a P/B of 2.5, Nutriband's ratios suggest it is trading at a discount. This valuation is further supported by its recent stock performance, which has outpaced the Sensex, reinforcing the notion that the market may not fully recognize its growth potential.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Poor Management Efficiency with a low ROE of 0%

  • The company has reported losses. Due to this company has reported negative ROE
2

Flat results in Jul 25

3

Risky - Negative EBITDA

4

Underperformed the market in the last 1 year

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 70 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.54

stock-summary
Return on Equity

-117.77%

stock-summary
Price to Book

13.68

Revenue and Profits:
Net Sales:
1 Million
(Quarterly Results - Apr 2025)
Net Profit:
-1 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-20.31%
0%
-20.31%
6 Months
-34.37%
0%
-34.37%
1 Year
22.22%
0%
22.22%
2 Years
88.1%
0%
88.1%
3 Years
27.78%
0%
27.78%
4 Years
5.79%
0%
5.79%
5 Years
-58.63%
0%
-58.63%

Nutriband, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Nutriband Stock Forms Death Cross, Signaling Bearish Trend Ahead

Nutriband Stock Forms Death Cross, Signaling Bearish Trend Ahead

Nutriband, Inc. has recently encountered a technical event known as a Death Cross, indicating a potential shift in market sentiment. Current indicators reflect a bearish outlook, with significant declines over the past month and year-to-date performance lagging behind the broader market, raising concerns about its financial health.

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
22.87%
EBIT Growth (5y)
-236.85%
EBIT to Interest (avg)
-4.70
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.54
Sales to Capital Employed (avg)
0.25
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
4.22%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
16.83
EV to EBIT
-13.38
EV to EBITDA
-14.00
EV to Capital Employed
35.37
EV to Sales
34.66
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-264.34%
ROE (Latest)
-117.77%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Apr 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 2 Schemes (2.35%)

Foreign Institutions

Held by 2 Foreign Institutions (0.03%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Apr'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Apr 2025 is 16.67% vs 0.00% in Jan 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Apr 2025 is 74.55% vs -292.86% in Jan 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Apr'25",
        "Jan'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.70",
          "val2": "0.60",
          "chgp": "16.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.40",
          "val2": "-1.90",
          "chgp": "26.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-3.60",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.40",
          "val2": "-5.50",
          "chgp": "74.55%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-2,117.80%",
          "val2": "-3,056.70%",
          "chgp": "93.89%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Jan'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Jan 2025 is 0.00% vs 0.00% in Jan 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Jan 2025 is -90.91% vs -22.22% in Jan 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jan'25",
        "Jan'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2.10",
          "val2": "2.10",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-6.40",
          "val2": "-4.60",
          "chgp": "-39.13%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.10",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-4.00",
          "val2": "-0.60",
          "chgp": "-566.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-10.50",
          "val2": "-5.50",
          "chgp": "-90.91%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-3,126.70%",
          "val2": "-2,336.30%",
          "chgp": "-79.04%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Apr'25 - QoQstock-summary
Apr'25
Jan'25
Change(%)
Net Sales
0.70
0.60
16.67%
Operating Profit (PBDIT) excl Other Income
-1.40
-1.90
26.32%
Interest
0.00
0.00
Exceptional Items
0.00
-3.60
100.00%
Consolidate Net Profit
-1.40
-5.50
74.55%
Operating Profit Margin (Excl OI)
-2,117.80%
-3,056.70%
93.89%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Apr 2025 is 16.67% vs 0.00% in Jan 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Apr 2025 is 74.55% vs -292.86% in Jan 2025

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Jan'25stock-summary
Jan'25
Jan'24
Change(%)
Net Sales
2.10
2.10
Operating Profit (PBDIT) excl Other Income
-6.40
-4.60
-39.13%
Interest
0.00
0.10
-100.00%
Exceptional Items
-4.00
-0.60
-566.67%
Consolidate Net Profit
-10.50
-5.50
-90.91%
Operating Profit Margin (Excl OI)
-3,126.70%
-2,336.30%
-79.04%
USD in Million.
stock-summary Compare with Peers
Net Sales

YoY Growth in year ended Jan 2025 is 0.00% vs 0.00% in Jan 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Jan 2025 is -90.91% vs -22.22% in Jan 2024

All Annual Resultsstock-summary
stock-summaryCompany CV
About Nutriband, Inc. stock-summary
stock-summary
Nutriband, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."